Concord Medical - Spon ADRCCM
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$4.00avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($1K), UBS Group AG ($868) and SBI Securities Co., Ltd. ($16).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 2,607 shares sold, net −2,607 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Reduce -88.0% | 295 | $1K |
| UBS Group AG | 0.00% | Reduce -67.1% | 217 | $868 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $16 |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.